Paid Clinical Trials in New York

Candace Kastanis

Written by Candace Kastanis

Chemistry B.S. | UC Davis | Clinical Lab Technician

Updated & Fact Checked 7/25/26

New York Research For Healthy Volunteers

Paid Clinical Trials in Kansas City

New York State is not the same as New York City, so don’t get confused. Here we’re looking at the state of New York, and which paid clinical trials for healthy volunteers nearby might be available to you. Given that this is one of the oldest, most historical regions of the country, there are quite a lot of opportunities to choose from.

As of July 2026, 4,461 studies are actively recruiting volunteers across New York State, according to ClinicalTrials.gov — one of the largest totals in the country. Memorial Sloan Kettering, NYU Langone, Mount Sinai, and Montefiore anchor the city; the University of Rochester carries much of upstate.

Compensation is standard for most of these studies, covering time and travel, and New York’s density means many volunteers can reach multiple research centers by transit.

Quick Facts: Paid Clinical Trials in New York

  • Actively recruiting studies (July 2026): 4,461 (ClinicalTrials.gov)
  • Typical compensation: $50–$100 per completed outpatient visit; residential Phase 1 studies pay more (see highest paid clinical trials)
  • Cost to participate: $0 — study care and visits are covered by the sponsor
  • Worth knowing: Upstate residents: the University of Rochester is a top-five trial site statewide — you don’t need to travel to NYC for most studies

What’s being studied in New York right now

We sampled recruiting New York studies on ClinicalTrials.gov in July 2026. The most active sites and most-studied conditions:

Most active research sitesMost-studied conditions
Memorial Sloan Kettering Cancer Center (148 site listings)Breast cancer
NYU Langone Health (75)Prostate cancer
Icahn School of Medicine at Mount Sinai (55)Multiple myeloma
Montefiore Medical Center, Bronx (44)Advanced solid tumors
University of Rochester (43)Obesity

New York City holds most of the volume, but upstate is far from empty: the University of Rochester ranks among the state’s five most active sites, and Buffalo and Albany have programs through their regional systems.

Demographic Data Reveals Availability in New York

The same link that gave us the population provides demographic data. When it comes to paid clinical trials nearby for healthy volunteers, this data is very important. For New York State, 62.31% of the population are white, 15.39% of the population are black or of African descent, 8.58% are Asian, 8.56% are of other races, and 4.72% of the population has 2 or more ethnicities in their genetic background. The average age in the state is 39, with 51.45% of the population female, and 48.55% of the population being male.

Response to Treatment With Intravenous Abatacept Adults With Rheumatoid Arthritis
Recruiting
The immune system of patients with Rheumatoid Arthritis (RA) is different from that of people who do not have RA. The purpose of this study is to examine immune cells and proteins before subjects start to take study medication and after subjects start treatment with an approved therapy for RA, abatacept that will be given in combination with Methotrexate and/or anti-rheumatic drugs (DMARDS) that are approved for the treatment of RA. This study will assess whether subjects have clinically respond... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/23/2019
Locations: New York University Langone Health, New York, New York
Conditions: Rheumatoid Arthritis
Development of Childhood Anti-influenza Immunity
Recruiting
More information is needed on how children fight off influenza virus, as they are at greater risk for developing severe influenza infection and tend to have weaker responses to influenza vaccination. The purpose of this study is to understand how a child's early exposure to influenza vaccine or infection with influenza virus prepares him or her to combat future infections with this virus. Investigators will learn about how protection develops following an influenza infection or vaccination and t... Read More
Gender:
All
Ages:
Between 3 months and 15 years
Trial Updated:
07/15/2020
Locations: University of Rochester, Rochester, New York
Conditions: Influenza, Human
Prospective Randomized Controlled Trial Describing the Recurrence Rate of Adenomas in Sessile or Flat Colonic Lesions 15mm or Larger Receiving Post-resection Site Treatment With Snare Tip Soft Coagulation
Recruiting
A multi-center randomized controlled trial in only 24 patients showed a significant reduction of the recurrence rate by treatment of the normal appearing perimeter of the EMR defect using the argon plasma coagulator (2). A recent non-randomized trial suggested a substantial reduction by treatment of the perimeter with the snare tip in the soft coagulation mode (3).
Gender:
All
Ages:
Between 25 years and 99 years
Trial Updated:
08/07/2020
Locations: NYU Langone Health, New York, New York
Conditions: Colon Polyp
Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Recruiting
The purpose of this study is to offer a novel cancer vaccine called poly-ICLC (Hiltonol®) for subjects with malignant pleural mesothelioma by directly injecting the vaccine into the tumor. This trial will enroll a maximum of 18 patients with biopsy proven malignant pleural mesothelioma who are surgically resectable. Subjects will undergo core biopsies of their mesothelioma followed by direct injection of Poly ICLC, a TLR3 agonist which has been shown to have biological and immunological effects... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
04/10/2020
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Mesothelioma
A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness
Recruiting
There is currently no treatment available for COVID-19, the acute respiratory illness caused by the novel SAR-CoV-2. Convalescent plasma from patients who have recovered from COVID-19 that contains antibodies to the virus is a potential therapy. On March 25th, 2020, the FDA approved the use of convalescent plasma under the emergency investigational new drug (eIND) category. Randomized trials are needed to determine the efficacy and safety of COVID-19 convalescent plasma for acute COVID-19 infect... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
07/06/2020
Locations: Brooklyn Methodist Hospital, Brooklyn, New York +2 locations
Conditions: COVID-19
Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia
Recruiting
To evaluate the efficacy and safety of cariprazine at a target dose of 4.5 mg/d compared with placebo in prevention of relapse in patients with schizophrenia To evaluate the efficacy and safety of cariprazine at a target dose of 3.0 mg/d compared with placebo in prevention of relapse in patients with schizophrenia who were initially stabilized on a target dose of 4.5 mg/d
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
08/17/2020
Locations: Neurobehavioral Research Inc, Cedarhurst, New York
Conditions: Schizophrenia
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
The present study D5272C00001 (Legacy # 3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/19/2021
Locations: Research Site, New York, New York +1 locations
Conditions: Ulcerative Colitis
Delphi Early Feasibility Study
Recruiting
An early feasibility study to evaluate the safety and first pass effect technical assessment of Delphi Revascularization Device for clot retrieval in Anterior circulation ischemic stroke in the intracranial ICA, MCA M1 and proximal dominant MCA M2, up to 8hrs of symptom onset or Last Known Well (LKW).
Gender:
All
Ages:
18 years and above
Trial Updated:
08/19/2021
Locations: kaledia Health/Buffalo General Medical Center/GVI, Buffalo, New York
Conditions: Ischemic Stroke
COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age
Recruiting
The primary objective of the study is to characterize the concentrations of casirivimab+imdevimab in serum over time after a single subcutaneous (SC) administration The secondary objectives of the study are: To assess the safety and tolerability of SC or single administration of casirivimab+imdevimab To assess the occurrence of grade ≥3 injection site reactions and grade ≥3 hypersensitivity reactions, in participants treated with SC doses of casirivimab+imdevimab To assess the immunogenicity o... Read More
Gender:
All
Ages:
12 years and below
Trial Updated:
12/06/2021
Locations: Jacobi Medical Center, Bronx, New York +1 locations
Conditions: COVID-19
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
Recruiting
The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.
Gender:
All
Ages:
Between 18 years and 130 years
Trial Updated:
01/14/2022
Locations: Research Site, New York, New York +2 locations
Conditions: Chronic Lymphocytic Leukemia

Interpreting New York Demographic Information to Identify Paid Trials

The majority of opportunities in paid clinical trials for healthy volunteers will be for adult women in their late thirties, followed by adult men in the same category. Keep in mind, studies tend to lean toward increased diversity in participants, as this provides more robust data. However, there will always be situations where specific volunteers are needed. It will depend on the CRO. Generally, you should be able to find opportunities throughout the state that fit you; this demographic data just helps direct your search.


New York CROs Healthy Participants Might Explore For Opportunities

In order to help you explore healthy volunteer paid clinical trials, here are three options from different areas in the state to consider:

  • Panigen in the State’s Central Western Region
  • Parexel in the Southeast of the State
  • Polycontrols in the Northeast of the State

Medical Trends in New York That Have Influenced the Science

New York City is well known for its breakthroughs, and these are central to New York State. The bottom line is, there are some true historical opportunities in the area you can be a part of if you like. Here are three well-known breakthroughs that New York can lay claim to:


New York Paid Clinical Trial FAQs

  • How much do paid clinical trials pay in New York?

    Most outpatient studies in New York pay $50–$100 per completed visit, plus travel reimbursement — often including transit fare in the city. Residential Phase 1 studies pay considerably more. The exact amount appears in the consent form before you enroll.

  • Where are most clinical trials in New York?

    New York City dominates, led by Memorial Sloan Kettering, NYU Langone, Mount Sinai, and Montefiore. Upstate, the University of Rochester runs one of the state’s largest programs, with additional options in Buffalo and Albany.

  • Do New York trials cover travel within the city?

    Many do. Travel reimbursement is standard in most studies, and city-based sites often cover transit fare or ride services for study visits. Ask the coordinator what is included before you enroll.

New York CRO Trial Opportunities Healthy Volunteers Might Consider

New York State has a deep history, and that extends to the field of medicine. Through paid clinical research trials, you can take part in that history, and make a little money at the same time.